Sign in

NIVF on Nasdaq

NewGenIvf Group Ltd

NewGenIvf Group Ltd is a misc health and allied services company, active since 2023.2 It is headquartered in Tortola, British Virgin Islands.2

Price unavailable

Last updated Oct 21, 2026.

Overview

$4.7MRevenue, fiscal 20253
$9.9MNet income, fiscal 20253

Compare with Charming Medical Ltd, PACIFIC HEALTH CARE ORGANIZATION INC or Marpai, Inc., or pick any stock.

  • TickerNIVF on Nasdaq2
  • IndustryServices-Misc Health & Allied Services, NEC2
  • HeadquartersTortola, British Virgin Islands2
  • Incorporated inVirgin Islands, British4
  • Business address13/F, Ps Tower, Sukhumvit 21 Rd (Asoke), Bangkok, W1 00004
  • Filer category, Emerging growth company4
  • Legal formcompany limited by shares2
  • LEI529900163F6FNC6AUM872
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressc/o Ogier Global (BVI) Limited, Ritter House, Wickhams Cay II, Po Box 3170, VG1110 Tortola, British Virgin Islands2
  • Registered withRegistry of Corporate Affairs (British Virgin Islands Financial Services Commission), 21169882

See how the biggest companies compare on our leaderboards

Mini Acquisition Corp.” means A SPAC I Mini Acquisition Corp., a British Virgin Islands business company.5 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

20.2%Gross margin3
-226.9%Operating margin3
209.0%Net margin3
-13.0%Revenue growth, 20253
37.1%Return on equity3
-$11.1MFree cash flow3

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

IVFTreatment Service brought in 83% of the revenue NewGenIvf Group Ltd broke down this way in fiscal 2025.

  1. IVFTreatment Service$3.9M383%down 28% from 2024
  2. Fertility Referral Services$820.6K317%
Products and services by year
Products and services20242025
IVFTreatment Service$5.4M$3.9M
Fertility Referral Services$820.6K

Regions

KG brought in 47% of the revenue NewGenIvf Group Ltd broke down this way in fiscal 2025.

  1. KG$2.3M347%down 13% from 2024
  2. TH$1.7M334%down 22% from 2024
  3. KH$635.2K313%up 6% from 2024
  4. Hong Kong$209.6K34%up 6704% from 2024
  5. United States$45.5K31%
  6. China HKSARMember$41.6K31%
Regions by year
Regions20242025
KG$2.7M$2.3M
TH$2.2M$1.7M
KH$601.5K$635.2K
Hong Kong$3.1K$209.6K
United States$45.5K
China HKSARMember$41.6K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue28¢$3.8M
  • Profit72¢$9.9M

Out of $4.7M in revenue.3

Financial statements

Revenue673$4.7M in 2025+15% since 2021
0$2.0M$4.0M$6.0M2021: $4.1M$4.1M20212022: $5.9M$5.9M2022+44%2023: $5.1M$5.1M2023−14%2024: $5.4M$5.4M2024+6%2025: $4.7M$4.7M2025−13%
Gross profit673$955.8K in 2025−7% since 2021
0$500.0K$1.0M$1.5M$2.0M2021: $1.0M$1.0M20212022: $1.5M$1.5M2022+50%2023: $1.7M$1.7M2023+9%2024: $1.8M$1.8M2024+9%2025: $955.8K$955.8K2025−48%
Operating income673-$10.7M in 2025
-$15.0M-$10.0M-$5.0M0$5.0M2021: $198.8K$198.8K20212022: $398.7K$398.7K2022+101%2023: $42.2K$42.2K2023−89%2024: -$1.2M-$1.2M20242025: -$10.7M-$10.7M2025+824%
Net income673$9.9M in 2025
-$5.0M0$5.0M$10.0M2021: -$533-$53320212022: $458.7K$458.7K20222023: $130.2K$130.2K2023−72%2024: -$524.6K-$524.6K20242025: $9.9M$9.9M2025

Every line of the income statement as filed: the last 3 fiscal years, latest first.3

Period ending2025-12-312024-12-312023-12-31
Revenues$4.7M$5.4M$5.1M
Cost of revenues-$3.8M-$3.6M-$3.5M
Gross profit$955.8K$1.8M$1.7M
Selling and marketing expenses-$1.2M-$206.3K-$18.0K
General and administrative expenses-$10.5M-$2.8M-$1.6M
Total operating expenses-$11.7M-$3.0M-$1.6M
Operating (loss) income-$10.7M-$1.2M$42.2K
Other income, net-$8.1K$971.4K$111.8K
Bargain purchase gain$21.7M
Loss on digital assets, net-$332.5K
Loss on financial assets, net-$700.6K
Gain on embedded derivative$456.7K
Interest income$2.3K$7.0K$518
Interest expense-$616.4K-$778.7K-$46.2K
Total other income (expenses), net$20.5M$199.7K$66.2K
Income (Loss) before taxes$9.7M-$960.8K$108.4K
Tax income (expense)$486.7K
Net income (loss)$9.7M-$474.1K$108.4K
Less: net (loss) income attributable to non-controlling interests-$150.7K$50.5K-$21.8K
Net income (loss) attributable to the shareholders of the Company$9.9M-$524.6K$130.2K
Foreign currency translation adjustment-$222.9K$32.5K-$22.7K
Total comprehensive (loss) income$9.5M-$441.6K$85.7K
Less: total comprehensive (loss) income attributable to non-controlling interests-$211.7K$56.9K-$27.6K
Total comprehensive income (loss) attributable to the shareholders of the Company$9.7M-$498.5K$113.3K
Earnings per share basic (in Dollars per share)$214.73-$4,408.76$13,019.30
Earnings per share diluted (in Dollars per share)$3.04-$4,408.76$13,019.30
Weighted average shares outstanding basic (in Shares)46.0K shares119 shares10 shares
Weighted average shares outstanding diluted (in Shares)3.3M shares119 shares10 shares

Compare NewGenIvf Group Ltd with another company

Corporate structure

NewGenIvf Group Ltd sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of NewGenIvf Group Ltd

  • NewGenIvf Group Ltd Tortola, British Virgin Islands

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What NewGenIvf Group Ltd reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$3.0M3 Dec 31, 2025$1.5M3 Dec 31, 2024+99.5%
Accumulated depreciation$1.2M3 Dec 31, 2025$1.2M3 Dec 31, 2024−0.9%
Property and equipment, net$1.8M3 Dec 31, 2025$273.1K3 Dec 31, 2024+555.1%
Operating-lease assets (leased space)$504.2K3 Dec 31, 2025$98.6K3 Dec 31, 2024+411.5%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$758.6K3 Dec 31, 2025$457.7K3 Dec 31, 2024+65.7%

Intangibles and goodwill

ItemLatestA year beforeChange
Intangible assets, net (excluding goodwill)$21.4M3 Dec 31, 2025

Inventory

ItemLatestA year beforeChange
Inventory, total$335.4K3 Dec 31, 2025$80.8K3 Dec 31, 2024+315.0%

Leadership

Who has led NewGenIvf Group Ltd, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Wing Fung Alfred Siu2026–now

Chair

  1. Wing Fung Alfred Siu2026–now

Chief financial officer

  1. Chung Ho Chan2026
  2. Ho Fai Chung2026–now
Board members and other officers (9)

Former names

  • ASPAC I Mini Acquisition Corp.Jun 16, 2023 to Mar 1, 20244

Timeline

  1. Mar 31, 2026New chief executive Wing Fung Alfred Siu becomes CEO8
  2. Jan 26, 2023Founded NewGenIvf Group Ltd is founded2

Filings

182 filings to the SEC since October 2021: 5 annual reports, 1 major events, 29 insider forms, 8 large holders, 139 other. The latest 20:

  1. Oct 7, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  2. Oct 7, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  3. Oct 6, 2026SCHEDULE 13D/A EDGAR
  4. Oct 6, 20264 EDGAR
  5. Oct 6, 20264 EDGAR
  6. Oct 5, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  7. Sep 30, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  8. Sep 30, 2026424B4 PROSPECTUS EDGAR
  9. Sep 28, 2026EFFECT EDGAR
  10. Sep 10, 2026F-1/A AMENDMENT NO. 2 TO FORM F-1 EDGAR
  11. Sep 4, 20263 EDGAR
  12. Sep 2, 20263 EDGAR
  13. Sep 2, 20264 EDGAR
  14. Sep 2, 20263 EDGAR
  15. Sep 1, 2026F-1/A AMENDMENT NO. 1 TO FORM F-1 EDGAR
  16. Aug 20, 2026F-1 REGISTRATION STATEMENT EDGAR
  17. Aug 20, 20263 EDGAR
  18. Aug 18, 20266-K REPORT OF FOREIGN PRIVATE ISSUER EDGAR
  19. Aug 18, 20264 EDGAR
  20. Aug 18, 20264 EDGAR

The 182 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

10 open-market trades by officers, directors and large owners since October 2021: 8 buys and 2 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 27, 2026Cheung Kong YiuDirectorBuy2,500,000$1.00$2.5MForm 4
Jun 18, 2026Cheung Kong YiuDirectorBuy500,000$1.33$665.0KForm 4
Jun 4, 2026HRT FINANCIAL LP10% ownerSale64,945$0.78$50.7KForm 4
Jun 3, 2026HRT FINANCIAL LP10% ownerBuy11,738$0.88$10.3KForm 4
Jun 2, 2026HRT FINANCIAL LP10% ownerBuy23,018$0.94$21.6KForm 4
Jun 2, 2026Cheung Kong YiuDirectorBuy500,000$1.33$665.0KForm 4
May 28, 2026Cheung Kong YiuDirectorBuy222,223$1.50$333.3KForm 4
May 27, 2026HRT FINANCIAL LP10% ownerSale85,317$0.80$68.3KForm 4
May 26, 2026HRT FINANCIAL LP10% ownerBuy27,993$0.92$25.8KForm 4
May 22, 2026HRT FINANCIAL LP10% ownerBuy137,541$0.99$136.2KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How NewGenIvf Group Ltd is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARNewGenIvf Group Ltd1
  • CIK0001981662
  • Filer statusNon-accelerated filer an emerging growth company; not a shell company5
  • Incorporated inBritish Virgin Islands5
  • Industry code (SIC)8090 Services-Misc Health & Allied Services, NEC1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address13/F, Ps Tower, Sukhumvit 21 Rd (Asoke), Bangkok, W1 00001
  • Mailing address1/F, Pier 2, Central, Hong Kong, K3 9990771
  • Phone852-2861-16661
  • Shares outstanding240,622 Common Class A shares; 380 Common Class B shares as of Dec 31, 20255
  • AuditorJ&S Associate PLT, Kuala Lumpur, Malaysia PCAOB ID 6743; no auditor attestation of internal control over financial reporting5
  • On EDGAR sinceJun 16, 20231
  • Filings182 in all: 6-K (54), UPLOAD (16), 4 (15), CORRESP (15), 3 (13), F-1/A (11), F-1 (7), 424B3 (6)1
    All 27 form types

    EFFECT (6), DRS (5), 20-F (4), DRS/A (4), DRSLTR (4), F-4/A (4), SC 13G (4), 425 (2), SCHEDULE 13D/A (2), 20-F/A (1), 3/A (1), 424B4 (1), 6-K/A (1), 8-K12B (1), F-4 (1), NT 20-F (1), RW (1), SC 13D (1), SC 13G/A (1)

  • Latest filingsAnnual report (20-F) Mar 31, 2026

Securities registered for trading

ClassSymbolExchange
Class A ordinary shares, no par value per shareNIVFThe Nasdaq Stock Market LLC
Warrants to purchase Class A ordinary sharesNIVFWThe Nasdaq Stock Market LLC

From the cover page of the 20-F filed Mar 31, 2026 (Section 12(b) of the Exchange Act).5

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24